Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Every dose from 0.5mg to 4mg falls between 10 and 80 units, all easily readable on a U-100 syringe
Semaglutide has a plasma half-life of approximately 165 hours (roughly 7 days), enabling once-weekly dosing
Injection site reactions, including erythema, pruritus, and nodule formation (particularly with extended-release formulations), occur in approximately 10-20% of patients
Elife 10 , e69209 (2021)
Clinical Data Clinical Trial Results 28.7% Average Weight Loss 68 weeks 58.6% Achieved 25%+ Loss of participants 445 Trial Participants Phase 3 Data from the Phase 3 TRIUMPH-4 trial of retatrutide, reported by Eli Lilly (topline, 2025)
Rather than dismissing his interest, I suggested a compromise: He could try the ACV approach, but wed monitor his blood sugar closely, and if we didnt see meaningful improvement within a month, hed start the medication
